
There won’t be a single cancer vaccine, but rather a different one for each patient and tumor
After decades of setbacks, a treatment for melanoma is very close to being approved

After decades of setbacks, a treatment for melanoma is very close to being approved

The researcher has penned crime novels full of death — and received more than $5.8 million from the European Union toward finding the cure for cancer

The Yale-educated physician joined the company in 2020 to help people find credible health information online and answer common questions that users ask on the platform

Spanish biochemist Héctor Méndez and his colleagues from the University of Florida have achieved ‘promising’ results in their initial human trial

Preliminary study of messenger RNA therapy against propionic acidaemia shows it is safe, but doubts remain about its usefulness

The Food and Drug Administration decision opens the newest shots from Moderna and Pfizer and its partner BioNTech to most Americans even if they’ve never had a coronavirus vaccination

European countries are negotiating with pharmaceutical companies to avoid accumulating unused doses

Research and development expenses nearly doubled to $1.2 billion for the drugmaker

The study found that combining mRNA technology with a cancer drug reduces the risk of recurrence or death by 44%

The company accuses its competitors of copying its messenger RNA technology without its permission